A new trading day began on Monday, with Vistagen Therapeutics Inc (NASDAQ: VTGN) stock price up 16.32% from the previous day of trading, before settling in for the closing price of $3.8. VTGN’s price has ranged from $1.90 to $4.65 over the past 52 weeks.
During the last 5-year period, the sales growth of Healthcare Sector giant was 35.63%. Meanwhile, its annual earnings per share averaged 0.45%.
Vistagen Therapeutics Inc (VTGN) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Vistagen Therapeutics Inc is 9.06%, while institutional ownership is 57.88%.
Vistagen Therapeutics Inc (VTGN) Recent Fiscal highlights
In its latest quarterly report, released on 12/31/2024, the company reported earnings of -0.46 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.37 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 0.45% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 26.61% during the next five years compared to 35.63% growth over the previous five years of trading.
Vistagen Therapeutics Inc (NASDAQ: VTGN) Trading Performance Indicators
Here are Vistagen Therapeutics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 5.79. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 249.38.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.58, a number that is poised to hit -0.35 in the next quarter and is forecasted to reach -1.79 in one year’s time.
Technical Analysis of Vistagen Therapeutics Inc (VTGN)
Looking closely at Vistagen Therapeutics Inc (NASDAQ: VTGN), its last 5-days average volume was 0.65 million, which is a jump from its year-to-date volume of 0.33 million. As of the previous 9 days, the stock’s Stochastic %D was 36.31%.
During the past 100 days, Vistagen Therapeutics Inc’s (VTGN) raw stochastic average was set at 86.93%, which indicates a significant increase from 68.91% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.34 in the past 14 days, which was higher than the 0.25 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.79, while its 200-day Moving Average is $2.89. However, in the short run, Vistagen Therapeutics Inc’s stock first resistance to watch stands at $4.89. Second resistance stands at $5.35. The third major resistance level sits at $5.92. If the price goes on to break the first support level at $3.86, it is likely to go to the next support level at $3.29. Now, if the price goes above the second support level, the third support stands at $2.82.
Vistagen Therapeutics Inc (NASDAQ: VTGN) Key Stats
With a market capitalization of 174.57 million, the company has a total of 30,680K Shares Outstanding. Currently, annual sales are 490 K while annual income is -51,420 K. The company’s previous quarter sales were 240 K while its latest quarter income was -15,100 K.
